NCT00004162View on ClinicalTrials.gov

Liposomal Doxorubicin Plus Combination Chemotherapy in Treating Patients With AIDS-Associated Non-Hodgkin's Lymphoma

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

June 30, 1997

Primary Completion Date

January 31, 2001

Study Completion Date

January 31, 2001

Conditions
Lymphoma
Interventions
BIOLOGICAL

sargramostim

DRUG

methotrexate

DRUG

pegylated liposomal doxorubicin hydrochloride

DRUG

vincristine sulfate

Trial Locations (1)

35294

University of Alabama Comprehensive Cancer Center, Birmingham

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Alabama at Birmingham

OTHER

NCT00004162 - Liposomal Doxorubicin Plus Combination Chemotherapy in Treating Patients With AIDS-Associated Non-Hodgkin's Lymphoma | Biotech Hunter | Biotech Hunter